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Trans-resveratrol (3, 5, 4’ trihydroxystilbene, RSV) is a natural compound that shows 
antioxidant, cardioprotective, anti-inflammatory and anticancer properties. The transdermal, 
painless application of RSV is an attractive option to other administration routes owing to its 
several advantages like avoiding gastrointestinal problems and first pass metabolism. However, its 
therapeutic potential is limited by its low solubility and low stability in water and the reduced 














compound in a drug delivery system is proposed here. In order to find the best carrier for 
transdermal application of RSV various liposomal nanoparticulate carriers like conventional 
liposomes (L-RSV), deformable liposomes (LD-RSV), ultradeformable liposomes (LUD-RSV) and 
ethosomes (Etho-RSV) were assayed. Transmission electron microscopic (TEM) and dynamic light 
scattering (DLS) studies were performed to analyze the surface morphology of these carriers. 
Structural characterization for these formulations was performed by confocal Raman 
spectroscopy. The spectroscopic results were analysed in conjunction with calorimetric data to 
identify the conformational changes and stability of formulations in the different nanoparticles 
induced by the presence of RSV. 
Comparison of the results obtained with the different carrier systems (L-RSV, LD-RSV, LUD-
RSV and Etho-RSV) revealed that the best RSV carrier was LD-RSV. The increase in the fluidity of 
the bilayers in the region of the hydrophobic chains of the phospholipid by ethanol probably 
facilitates the accommodation of the RSV in the bilayer and contributes to the improved 
encapsulation of RSV without affecting the mobility of this carrier. 
 
  






Resveratrol (3, 5, 4’ trihydroxystilben, RSV) is the main compound of stilbene phytoalexins 
which was first isolated from the roots of Polygonum cuspidatum. RSV is mainly found in peanuts, 
grapes and red wine [1][2] and exhibits interesting medical properties. The therapeutic potential 
of this compound is related to its antioxidant, cardioprotective, anti-inflammatory and anticancer 
ability properties [3][4][5] found specially in trans-RSV, more biologically active than the cis isomer 
[6]. Moreover, epidemiological studies showed an inverse correlation between red wine 














Transdermal, painless application of RSV is an attractive option to other administration routes 
to avoid gastrointestinal problems and first pass metabolism [8]. However, RSV therapeutic 
potential of this route is limited by the reduced permeability of stratum corneum which is the 
main obstruction for the drug transport. Besides, RSV solubility is low (0.03 g/L) and its stability in 
water is deficient due to photoisomerization that reduces RSV activity. These limitations could be 
resolved through encapsulation of RSV in novel drug delivery systems. Novel strategies to increase 
the permeation and thereby the absorption of drugs through the skin such as vesicles (liposomes) 
[9], nanoparticles [10][11] and nanodroplets [12] have been proposed for several compounds of 
medical interest. Among these strategies, vesicular drug delivery systems based on liposomes have 
been extensively studied as possible carriers of other compounds because of its similarity to cell 
membranes, biocompatibility and low toxicity. However, it has been reported that conventional 
liposomes would not be suitable as transdermal drug delivery systems as they do not penetrate 
into deeper regions of skin and are retained in the upper layers of the stratum corneum [13][14]. 
Accordingly, new strategies are focused in the synthesis of novel drug delivery systems that can 
penetrate into these depths of skin such as deformable lipid vesicles (elastic and ultraflexible), 
known as deformable liposomes or transferosomes [15][16]. Several studies have reported that 
these deformable liposomes have exhibited improved effectiveness in the in vitro release of 
hydrocortisone, dexamethasone and methotrexate and ability to penetrate into the deeper layers 
of skin, achieving the delivery of the actives to their therapeutic levels [17][18]. Delivery is 
facilitated by the osmotic gradient between the inner and outer layer of the stratum corneum [19] 
and by the flexibility and elasticity of these transferosomes that make their transport through the 
spaces between the cells that comprise the stratum corneum easier. This ability is not found in the 
traditional liposomes [20].  
Other novel vesicular drug delivery systems called ethosomes, developed by Touitou have 
also gained relevance in the last decade [13][21]. Ethosomes are noninvasive lipid vesicles 
containing high concentrations of ethanol which promote their penetration through the skin. This 
property makes them interesting as vehicles for topical drug delivery. Comparing with 
conventional liposomes or hydro alcohol solutions, the ethosomes diffuse more efficiently into the 
skin tissue due to its flexibility and malleability, improving drug delivery into deep layers such as 
the dermis and reaching the circulatory system [16][22]. Under high concentrations of ethanol the 
lipid membrane turns loose making the stratum corneum a soft structure with greater capacity for 














All in all, various liposomal nanoparticulate carriers for RSV like conventional liposomes (L-
RSV), deformable liposomes (LD-RSV), ultradeformable liposomes (LUD-RSV) and ethosomes 
(Etho-RSV) were assayed.  Comparison of the results obtained with the different carrier systems 
were made in order to select the best alternative for transdermal application of RSV. To the best 
of our knowledge this is the first time that the comparison of four different liposomes for 
transdermal release of RSV is reported and the more appropriate is selected with the aim of 
resolving the low permeability of RSV in the stratum corneum. With this purpose, size distribution, 
polydispersity index, surface morphology and encapsulation efficiency of the nano-carriers were 
evaluated. Transmission electron microscopic (TEM) and dynamic light scattering (DLS) studies 
were also performed to analyze their surface morphology. Additionally, structural characterization 
was achieved by confocal Raman spectroscopy. The spectroscopic results were complemented 
with calorimetric data to identify the conformational changes and stability of formulations in the 
different nanoparticles induced by the presence of RSV. 
 
 
2. MATERIALS AND METHODS  
 
2.1 Materials 
Soy phosphatidylcholine (Phospholipon® 90G, PL90) was purchased from Lipomize (Argentina 
- Lipoid GmbH, Ludwigshafen, Germany). Tween 80, chloroform and ethanol were purchased from 
Merck (Germany).  Resveratrol (Shaanxi Berries Biochemical Co, Ltda, RSV) was a gift from Elisium 
(Capital Federal, Buenos Aires, Argentina).  
 
2.2 Aqueous solution of RSV  
  
RSV has low solubility in water. It was solubilized by magnetic agitation for 1h at 27°C in 
darkness. Samples were protected from the light during preparation and were stored in an amber 
colored glass bottle to avoid photodegradation. The concentration of resveratrol studied was 65 















2.3 Preparation of carriers 
Suspensions were prepared by film method. Lipids and drug were dissolved in chloroform (10 
mL) and the organic solvent was removed by rotary evaporation (Büchi Rotavapor R-114) in a 
water bath at 40 °C (Büchi Waterbath B-480) and 70 cm Hg. Deposited lipid film was hydrated with 
Milli Q water by rotation. Suspensions were filtered three times through 450 µm Millipore. 
Incorporation of RSV in these systems was performed in the solvent because of its better solubility 
when compared with water. The samples were prepared in triplicate. Vials were kept refrigerated 
until the moment of analysis. 
 
2.3.1 Conventional liposomes (L and L-RSV) 
5 mg of RSV was dissolved in chloroform (10 mL) and mixed with 0.11 g of PL90. The solution 
was evaporated to form a thin film and was hydrated with 10 mL of Milli Q water. This was 
followed by 90 min agitation at room temperature to obtain large multilamellar vesicles. The 
mixture was divided into conical tubes and sonication for 2 min to obtain a translucent dispersion.  
The same procedure was followed in the preparation of blank liposomes without RSV (control, L).  
 
2.3.2 Deformable liposomes (LD and LD-RSV) 
15 mg of RSV was dissolved in chloroform and the PL90/Tween80 (1:4) mixture was added 
and mixed (LD-RSV). Film hydration was obtained with water: ethanol (7% v/v) and agitated for 1h 
at 39 ºC. The mixture was kept at rest for 2 hours to attain full hydration. Similarly, the blank 
deformable liposomes were prepared without RSV and used as control (LD). 
 
2.3.3 Ultradeformable liposomes (LUD and LUD-RSV) 
Ultradeformable liposomes were formulated with PL90, Tween 80 and cholesterol. The PL90 
and cholesterol (11:1) mixture was dissolved in chloroform. RSV was dissolved in chloroform 














added and stirred for 1 h.  Similar procedure was used in the preparation of blank ultradeformable 
liposomes without RSV which was used as control (LUD). 
 
2.3.4 Ethosomes (Etho and Etho-RSV) 
19 mg of RSV was dissolved in ethanol (3 mL) and 0.42 g of lipid was added to the drug 
solution.  7 mL of Milli Q water was added slowly in a fine stream to the above mixture with 
constant mixing at 750 rpm for 30 min at 35 ºC (EthoRSV). Samples were kept at rest for 2 h and 





2.4.1 UV-visible spectroscopy 
Aqueous RSV solution was scanned and the spectral absorbance was recorded in the range 
of 200-500 nm using a Shimadzu UV-Vis-NIR 3600 spectrophotometer with a 1 cm path length 
quartz cell (Figure S1, Supplementary information) 
 
2.4.2 Dynamic Light Scattering (DLS) 
Different dilutions for each of these suspensions were prepared in aqueous medium at 
room temperature. The particle sizes, polydispersity index (PI) and size distribution of these 
formulations were measured using a particle size analyzer (90Plus/BI-MAS) with He-Ne laser (658 
nm) and 15mW power. The average values were obtained from 3 measurements of 40 secs each 
one. A sample with a PI < 0.05 was considered as monodispersed [25]. 
 
2.4.3 Transmission Electron Microscopy (TEM) 
The samples were diluted (1:10) and maintained refrigerated until the measurement.  The 














of these various liposomes was examined using a JEOL 1200 EX II electron microscopic unit 
operated at 100 kV accelerating voltage (JEOL Ltd., Tokyo, Japan) and equipped with Erlangshen 
ES1000W (Gatan Inc., Pleasanton, California, USA) camera at Electronic Microscopy Center of 
Facultad de Ciencias Veterinarias  (UNLP, Argentine). 
 
2.4.4 Drug encapsulation efficiency of Resveratrol 
Determination of free/unencapsulated RSV from these formulations was carried out by 
dialysis through semipermeable membrane (D9527, Sigma Aldrich). The release system was 
maintained under magnetic stirring (100 rpm) at room temperature and immersed in glass flasks 
containing 250 mL of water. An aliquot of 1 mL of RSV aqueous solution was monitored by UV-vis 
spectroscopy at different times (40, 60, 120, 180, 240, 300, 360 min and 21 h). Results of 
encapsulation efficiency (E %) were calculated using the following equation (equation 1) and were 
expressed as the mean ± standard deviation (SD) of released RSV. It was calculated using the 
absorbance values of these solutions in the wavelength (λ) of 305 nm. 
 
                                                                                                          (1) 
 
where CI is initial concentration and CF is final concentration determined after dialysis. 
Experiments were performed at room temperature (27 °C) and at a pH of 6.5±0.1 [26]. Zupancic et 
al. [27] showed that RSV in aqueous solution was stable at room or body temperature at weakly 
acidic conditions of pH 6.8. Degradation of RSV is exponential above this pH value. The exposure 
to light and oxygen was avoided in order to maintain the stability of the trans isomer. The 
percentage of cumulative drug release (%CDR) profile of each delivery system was calculated. The 
















2.4.5 Differential Scanning Calorimetry (DSC) 
In this study, the effect of incorporation of RSV was investigated on the thermotropic 
behavior of lipid bilayers of different formulations. Calorimetric measurements were carried out 
by Shimadzu DSC-50 at a temperature range of -100 °C to 130 °C with 10 °C/min scanning speed. 
The maximum temperature of the transition endotherm (Tm) and the enthalpy (ΔH) were 
determined in the samples with and without RSV using N2 atmosphere with a 30 mL/min flux.  
 
2.4.6 Structural characterization by confocal Raman Spectroscopy 
Confocal Raman analysis was performed using a Rivers Diagnostics spectrometer (3510 SCA 
model) with 785 nm excitation (25 mW). The spectral range studied was from 400 to 1800 cm-1 
and 2700 to 3900 cm-1. The integration time of each spectrum was 10 s. The background due to 
the fluorescence of the skin tissue was corrected using a polynomial baseline correction and 
smoothing functions appropriate for each range. The peak positions were determined using 
second derivatives and subsequent deconvolution of the spectra.  
 
 
3. RESULTS AND DISCUSSION  
 
3.1 TEM, DLS and DSC Characterization 
The membrane stability of drug delivery systems generally depends on the composition, 
chemical structure and the nature of the encapsulated drug [27]. These factors may affect the 
permeability of the particles in biological environment, encapsulation of drugs and stability. The 
carriers loaded with RSV were characterized and compared with their controls through 
transmission electron microscopy (TEM), dynamic light scattering (DLS) and differential scanning 
calorimetry (DSC).  
 
3.1.1 Transmission Electron Microscopy (TEM) 
Figures 1 (a) and (b) show the images obtained for Etho and Etho-RSV. Spherical particles 














which seem to be a core and its bilayer environment. The average sizes of nanoparticles were 
similar, 136 ± 14 nm for Etho and 140 ±16 nm for Etho-RSV. Figures 1 (c) and (d) show images of 
TEM for deformable systems LD-RSV and LD, respectively.  Both samples were spherical but show 
heterogeneity in size. LD-RSV nanoparticles are more spaced to each other when compared with 
LD samples. According to the images, the average sizes are smaller for LD, 83 ± 10 nm than for LD-
RSV, 95 ± 12 nm and nanoparticles showing heterogeneity in size. Figures 1 (e) and (f) correspond 
to L and L-RSV. They show smaller nanoparticles for L but markedly larger for L-RSV (64.5 ± 14 nm 
and 176.5 ± 28 nm, respectively). Liposomes with RSV can be seen in a well-defined structure.  
Images of ultradeformable particles, LUD show particles with average size equal to 86 ± 12 
nm and, like L-RSV, LUD-RSV its size is almost double, 172,5 ± 27 nm, (Figure 1 (g) and (h)).  
 
3.1.2 Dynamic Light Scattering (DLS) 
The study of formulations reveals that the polydispersity index was less than 0.3 for all 
samples, with the exception of Etho. This sample presented a slightly higher value indicating that 
the particle population was relatively heterogeneous in size (Table 2). A larger size for Etho-RSV, L-
RSV and LUD-RSV than their controls (without RSV) was observed due the presence of RSV. It 
could be explained by the presence of RSV located in the lipid bilayer. It could also be associated 
to the gradient between the external aqueous environment and RSV dissolved in the aqueous core 
of the nanoparticles driving water into these particles by osmosis and causing an increase in size 
which is similar to swelling of the red blood cells in hypotonic solution. 
In the case of the deformable liposomes (LD and LD-RSV), both presented smaller sizes than 
other nanoparticles. This decrease can be related to the presence of ethanol which causes changes 
in the net charge of the system inducing steric stabilization which could lead to a decrease in the 
average size [30]. Ethanol content of ethosomes (30% v/v) is higher than LD systems (7% v/v), this 
influences positively on the mobility of the lipid bilayer. In addition, LD-RSV exhibits a size below 
10 nm compared with LD. This formulation also showed higher encapsulation than all the others. 
Based on these results, it can be concluded that there are more nanoparticles in this system and 















3.1.3 Differential Scanning Calorimetry (DSC) 
 
DSC analysis was performed to evaluate the effect of the incorporation of RSV on 
thermotropic behavior of lipid bilayers of nanoparticles. The transition temperature (Tm) and the 
enthalpy value (ΔH) were obtained for the samples with and without RSV. The measurements 
were made in the -75 °C to 75 °C temperature range and the scan range was 10 °C/min.  A single 
endothermic peak was detected (Table 3).  
Transition temperatures obtained for L and LUD showed no significant differences due to 
the incorporation of RSV, while, in the case of Etho and LD, the changes were 14.8° C and 3.11° C, 
respectively. It is known that at higher Tm values, the membrane acts as a fluid introducing some 
asymmetry in the hydrophobic part of the molecules. On the other hand, depending on the 
position of unsaturation in the hydrophobic portion, Tm may decrease [30]. Similar behaviour 
between nanoparticles when the values of phase transition enthalpy are obtained. Thus, the 
incorporation of RSV increased enthalpy values for LD-RSV and Etho-RSV. It is considered that the 
degree of order of lipids in the bilayers is reflected in the values of enthalpy. A lipid in asymmetric 
or amorphous state requires less energy than the ordered state to overcome the forces of 
cohesion [31]. Higher enthalpy values suggest that lipids have an orderly arrangement indicating a 
bilayer without major changes.  
Based on the results shown in Table 3, the values corresponding to the ethosomes, which 
increase significantly in size after the addition of RSV, are in agreement with those obtained by 
DLS. This indicates that RSV molecules are in the ethanolic core of ethosomes and the interaction 
with the lipid bilayer is weak (higher values of ΔH and ΔS) and the bilayer remains orderly cohesive 
but with some fluidity due to ethanol (higher values of Tm) [32]. LD and LD-RSV present behaviour 
similar to that of ethosomes. No marked changes in L-RSV and LUD-RSV were observed due to the 
presence of RSV compared with the controls. In case of conventional liposomes, there is a 
decrease of 0.57 °C (ΔTm) for the L-RSV while LUD-RSV exhibit an increase of 1.28 °C, related to the 
controls without RSV. This behavior may be associated with the low incorporation of RSV in such 
systems.  
Overall, TEM and DLS techniques confirmed the formation of spherical nanoparticles. 














taken into account the hydrodynamic ratio involved in the DLS measurements. DSC qualitative 
studies of the effect of RSV on the lipid bilayer of the nanoparticle revealed that RSV molecules 
can be found in the ethanolic nuclei in the EthoRSV, weakly interacting with the lipids of the 
bilayer, which remained orderly cohesive but with higher fluidity due to the presence of ethanol. 
The amount of ethanol used in the preparation of nanoparticles is enough for the formation of 
ethanolic nuclei and to promote a better fluidity of the lipid membrane without causing any 
disorder to the membrane. The changes in the Tm values of L-RSV and LUD-RSV were not 
pronounced, but express significant alterations in the bilayer due to the presence of RSV.  
 
3.2 Structural characterization by confocal Raman spectroscopy  
 
Trans-RSV molecule consists of two phenyl rings connected through an unsaturated 
double bond C=C with three hydroxyl groups in the rings. Considering the molecular vibrations of 
each group, the allocations to the peaks and Raman bands of RSV solution were made on the basis 
of theoretical knowledge and experimental data obtained from the various studies in the literature 
[33][34]. The molecular structure of RSV, with the numerical positions of atoms, was adapted from 
Vongsvivut [33] and it was utilized to describe the Raman vibrational modes where p is the 
position para (ring 1) and m is meta (ring 2) (Figure S2, Supplementary Information). 
Although there are many studies in the literature relating the use of Raman spectroscopy 
to evaluate liposomes and derivatives, most of them are oriented to direct applications of 
nanoparticles in biological systems [35]–[38] and very few studies analyze the composition of 
nanoparticles using Raman spectroscopy [39], [40]. Figure 2 represents the Raman spectra in low 
frequency (400-1800 cm-1) of Etho, Etho-RSV, L, L-RSV, LD, LD-RSV, LUD, LUD-RSV and aqueous 
solution of RSV (130 µM). This range is known as the fingerprint because it contains the main 
vibrational modes of the samples. The samples containing RSV were compared with the systems 
without RSV.  
Two regions of the spectra were analysed: (I) 1125-1340 cm-1 and (II) 1545-1715 cm-1. It is 
noted that LUD-RSV, Etho-RSV and LD-RSV samples exhibited significant spectral similarity in both 














the characteristic contributions of RSV except L-RSV that did not show changes in relation to L. The 
spectra of the controls LUD, LD and Etho are extremely similar with L as exception.  
In the regions I (1125-1340 cm-1) and II (1545-1715 cm-1) eight and four vibrational modes 
were analysed, respectively. According to Figure 2, intense bands were seen at 1607 and 1634 cm-1 
for Etho-RSV, LD-RSV, and LUD-RSV and at 1633 cm-1 for L-RSV. Both bands were attributed to 
combinations of stretching vibrations, ν(C=C) and deformations, δ (=C–H) of the double bond 
linking ring 1 and 2 associated with vibrations of para-OH (Op-H) of ring 1. The bands 
corresponding to 1603, 1627 and 1633 cm-1 are assigned to the spectrum of RSV solution.  In the 
same region, there is a vibrational mode at 1656 cm-1 assigned to ν(C=C) of alkyl chains (apolar 
part) of phosphatidylcholine for formulations without RSV (Etho, LD, L and LUD) [40]. This 
vibrational mode is present in all spectra with RSV and displayed as a shoulder of the broadband, 
which also contains the peaks related to RSV. Similarly, peak 1588 cm-1 attributed to O-H 
deformation of the p-position was found in the formulations containing RSV except L-RSV. 
Moreover the wavenumber was constant and of higher intensity in all spectra when compared to 
the aqueous solution of RSV. These vibrational modes indicate the existence of an overlap 
between the vibrational modes of RSV and the modes related to the alkyl chains. Additionally in 
the spectrum of RSV solution, a triple band at 1154, 1169 and 1176 cm-1 can be distinguished It has 
been assigned to deformation vibration, δ(C–H) of ring 2 and δ(C–H) and δ(Op–H) of ring 1 
associated with stretching ν(C10–C=) and ν(C–O) of ring 2.  
Spectra of nanoparticles containing RSV show an overlap of the 1169 and 1176  cm-1 peaks 
that leads to a single band at 1172 cm-1. In this region, no peaks related to vibrational modes of 
lipids were found. On the other hand, the spectra of nanoparticles without RSV, presented a 
characteristic peak at 1086 cm-1, related to stretching vibrational modes, ν(C-C) of  skeleton chain 
conformation gauche (indicative of a disorder of lipid chain). These vibrational modes are sensible 
to conformational state of the hydrocarbons chain [42]. In all spectra containing RSV, a decrease in 
the intensity value related to this peak was observed. However, Etho-RSV showed a peak at 1114 
cm-1 which is also related to gauche band. These characteristics can be associated with the fluidity 
of the lipid bilayer of nanoparticles. Moreover, in LUD-RSV spectrum a peak at 1064 cm-1 can be 
differentiated. It is associated with C-C stretching in trans conformation indicating an orderly 
chain. The gauche conformation may be related to increased mobility of hydrocarbon backbone 














gauche conformation can disappear or induce a reordering of the lipids. The contribution at 1207 
cm-1 is attributed to stretching between the carbon atoms located in the 4 and 8 positions, ν(C4-
C=) and indicates no significant change in all the spectra of the formulations with RSV except for  L-
RSV sample that presents a shift to 1215 cm-1. Vibrational modes related to lipids in this region 
were not found in the spectra of the formulations without RSV. The absence of vibrational modes 
associated with RSV molecule in the L-RSV sample may be connected with the low encapsulation 
and/or the location of RSV in the carriers. 1304 and 1314 cm-1 peaks attributed to RSV may be 
related to the vibrational mode of twist of CH2. This mode is found in the nanoparticles without 
RSV. In the presence of the compound, there is a sum of peaks that generates a wide band.  
Figure 3 shows the Raman spectra of formulations in the high frequency range of 2700 to 
3900 cm-1. In this region, major modes related to lipid molecules and water are included. The 
spectral differences in this region were used to identify conformational behaviour of the lipids 
constituting the nanoparticles. The conformational changes of the lipids in the nanoparticles with 
and without RSV are indicated in the Figure 3 in a grey stripe.  
Table 5 combines the band assignments according to the literature for the major peaks 
and changes in frequency values as a result of a structural change [33],[40][43]. The range 
comprised between 2850 and 3000 cm-1 is dominated by the presence of vibrations of ν(CH) 
associated with strong contributions of νsymCH2, νasymCH2 and harmonic binary interactions of δ 
(CH2) due to the Fermi resonance [43]. The bands around 2850, 2877 and 2882 cm-1 are associated 
with symmetric stretching νsym (CH2), νsym (CH3) and asymmetric stretching νasym (CH2) of lipid chains 
respectively. We observed CH3 group stretching only in the LD-RSV sample. When this sample was 
compared with its control (LD), it was observed that the intensity of the peaks related to the lipids 
decreased in the presence of RSV and absorbance bands were shifted from 2852 and 2902 cm-1 
(LD) to 2850 and 2908 cm-1 (LD-RSV). These characteristics may be related to the changes in lipid 
chains due to the presence of RSV either located in the bilayer or very close to these lipids.  
Comparing the intensities of peaks in the range of 2850 and 2930 cm-1 between Etho and 
Etho-RSV formulations, a decrease was observed for the samples of Etho-RSV. For this same 
sample a 2882 cm-1 peak related to νasym(CH2) disappeared and bands at 2902 cm-1 and 3012 cm-1 
related to vibrational modes ν(CH) and νasym(=CH) respectively appeared. The band located at 3012 
cm-1 is attributed unsaturated hydrocarbon chains stretching that are related to internal vibrations 














EthoRSV may be associated to RSV located in the bilayer because of the presence of molecules of 
ethanol that compose the bilayer. Three low intensity peaks related to lipids were observed in the 
spectrum of L sample.  Surprisingly, no peaks related to the lipids or RSV was found in L-RSV 
sample. A possible explanation for this observation is that the interaction of RSV with the lipids 
produced a total shift of these peaks to the region of vibrational modes of the water located (2726 
cm-1). The peaks at 2850 and 2882 cm-1 were analysed to estimate the relative population of trans 
and gauche conformations of alkyl lipid chains. The decrease in the peak intensity assigned to νasym 
CH2 (2882 cm-1) of CH2 is related to fewer trans conformations of lipid alkyl chains. Furthermore, a 
shift of 2850 cm-1 peak, νsym (CH2), towards shorter wavelengths indicates an increase in the trans 
population [46][47]. Shift in the Raman spectrum of LD-RSV from 2852 cm-1 to 2850 cm-1 indicates 
an increase of lipid chain order confirming the results obtained in the low frequency region. 
However, the 2884 cm-1 peak (νasym CH2) showed a significant decrease in its intensity. It is possible 
to have a mixture of ordered rearrangements between the chains as both these vibrational modes 
were observed in the samples containing RSV. These results clearly indicate that the presence of 
this compound influences the order of lipid bilayer in these nanoparticles.   
 All spectra considered, it is concluded that Raman spectroscopy served as a highly 
sensitive technique to detect conformational changes of nanoparticles due to the presence of RSV. 
In the low frequency region, the spectral changes owing to the presence of RSV in the 
nanoparticulate formulations can be clearly distinguished when compared with their respective 
controls (blank formulations). The fluidity of the bilayer increased maintaining the order was 
detected as a peak related to gauche conformation of the lipids in the Etho-RSV sample. These 
results were corroborated with those found in the DSC where the presence of ethanol in the 
bilayer promoted fluidity without disturbing the lipid chain. In the case of LUD-RSV spectral a 
change related to trans conformation was observed indicating the order of lipid chains. The 
presence of RSV may hide the appearance of the gauche conformation or may cause order in the 
lipids.  
In the high frequency region assigned to vibrational modes of lipids significant changes 
were found in the solutions containing RSV. Alterations in the intensity and displacement in 
wavelengths were found in the Etho-RSV samples in the characteristic region of lipid conformation 














results of LD-RSV were corroborated with the values found in low frequency region and 
calorimetry indicating the order of lipid bilayers.  
 
3.3 Drug encapsulation efficiency 
Absorbance spectra of aqueous solutions with 65µM concentration of trans-RSV indicated a 
characteristic band with peaks located in 305 and 317 nm. Hypsochromic effect was observed 
after 30 min of irradiation using the 370 nm lamp and 305 and 317 nm peaks (trans isomer) shifted 
to 287 and 316 nm (cis isomer), respectively were noticed [48]. Solutions were characterized in the 
200-400 nm range where the main information about isomers of RSV is located. Furthermore, 
absorbance values decreased mainly at 317 nm peak that disappeared after irradiation.  
RSV was released from vesicular systems using a dialysis membrane and was monitored 
through spectral absorption at 305 nm. After 40 min of dialysis, a characteristic band of RSV could 
be observed in all spectra. The release of RSV into the water from ethosomes and liposomes was 
greater than those of deformable and ultradeformable liposomes.  
The encapsulation efficiency (E %) values, shown in Table 1, correspond to the % of RSV 
encapsulated in the systems related to the total drug content. The highest value was measured for 
LD-RSV, followed by Etho-RSV, L-RSV and LUD-RSV. This could be explained due to the presence of 
the surfactant Tween 80 and the adequate amount of ethanol in the composition of deformable 
vesicles. Kronberg et al. reported that liposomes containing surfactant exhibit greater E (%) than 
the liposomes without this compound [49]. The presence of Tween did not affect the mobility of 
the polar groups. Additionally, there was an increase in the fluidity of the bilayers in the region of 
the hydrophobic chains of the phospholipid [50], which may improve encapsulation of RSV. On the 
other hand, the higher efficiency may also be related to the stabilizing action of ethanol in carriers 
so that the higher concentration of ethanol might provide increased membrane fluidity facilitating 
drug accommodation in the bilayer and a consequent increase in the E (%). Jain et al. related the 
encapsulation efficiency with the amount of ethanol. They reported that the presence of ethanol 
concentrations above certain limit creates instability and damage to the lipid bilayer [51]. 
Consequently, it seems that another factor could be related to the high solubility of RSV in ethanol 
(approx. 50 mg/mL) and may partly account for the decrease in the value of E (%) found in the 














dissolved in the ethanol / water mixture instead of being encapsulated in the ethosomes. The 
encapsulation effect of RSV was reflected in the size increase of nanoparticles observed by TEM 
microscopy and DLS. Etho-RSV incorporated 51% of RSV showing an increase of about 5% in the 
size compared with the control Etho. On the other hand, L-RSV and LUD-RSV with 23% and 12.6% 
of RSV encapsulated, respectively showed an increase in size of over 100%. LD-RSV showed 10% 
increase in the size even though the encapsulation efficiency was 91.8%. The capacity of 
encapsulation and the nanoparticles sizes are related to the characteristics of the lipid bilayers like 




In order to find the best carrier for transdermal application of RSV various liposomal 
nanoparticulate carriers like conventional liposomes (L-RSV), deformable liposomes (LD-RSV), 
ultradeformable liposomes (LUD-RSV) and ethosomes (Etho-RSV) were assayed and a comparative 
analysis of the results was made.  
Results revealed that the best RSV carrier was LD-RSV. This could be explained due to the presence 
of the surfactant Tween 80 and the adequate amount of ethanol in the composition of deformable 
liposomes. The increase in the fluidity of the bilayers in the region of the hydrophobic chains of 
the phospholipid by ethanol probably facilitates the accommodation of the RSV in the bilayer and 
contributes to the improved encapsulation of RSV without affecting the mobility of the carrier. LD-
RSV showed 10% increase in the size and 91.8% encapsulation efficiency. Other factors that 
contribute to the higher efficiency of LD-RSV than the other systems may be related to its 
adequate amount of ethanol that improves the solubility of RSV without damage or instability of 
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  Legends of Figures 
 
Figure 1. TEM images of carriers: (a) Etho, (b) Etho-RSV, (c) LD, (d) LD-RSV, (e) L,                 (f) L-RSV, 
(g) LUD, (h) LUD-RSV  
 




















































Table 1. Encapsulation efficiency in liposomal formulations 





































Table 2. Size and polydispersity index for all liposomal formulations 
Samples *Nanoparticle size *Polydispersity index 
Etho 131.8 ± 1.6 0.33 ± 0.01 
EthoRSV 289.6 ± 0.9 0.25 ± 0.005 
LD 94.9 ± 1.9 0.29 ± 0.03 
LDRSV 84.1 ± 1.0 0.28 ± 0.01 
L 149.3 ± 2.9 0.29 ± 0.1 
L-RSV 220.5 ± 2.2 0.22 ± 0.009 
LUD 131.2 ± 2.5 0.29 ± 0.005 
LUDRSV 201.3 ± 0.8 0.21 ± 0.03 






























Table 3. Thermodynamics parameters: Effect of RSV incorporated in the liposomes 
Samples Tma  (°C) ΔHb (J g-1 ) ΔSc (J g-1 K-1) 
L 4.51 350 1.26 
L-RSV 3.94 350 1.26 
Etho -1.04 120 0.46 
Etho-RSV 3.74 340 1.23 
LD 0.60 260 0.95 
LD-RSV 3.71 340 1.23 
LUD 3.54 340 1.23 
LUD-RSV 4.82 350 1.26 
aTm: Temperature for the maximum value of calorimetric peak.  
bΔH: Calorimetric enthalpy calculated as area under the curve. 
























Table 4. Wavenumbers (cm-1) of Raman spectra and description of vibrational modes of the RSV in 
aqueous solution and liposomal nanoparticles [33][34]. Region I (1125-1340 cm-1) and Region II 
(1545-1715 cm-1) are analysed.  














RSV  Etho-RSV  LD-RSV    L-RSV  LUD-RSV 
1153  1149  1149    1149 
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Table 5. Raman band assignments of different liposomal formulations [34], [41]-[44] 
 
 Samples Assignments 












 2726    2726   ν(OH) 
 2850 2850 2852 2850 2851 2852 2851 νsym(CH2) 
    2877    νsym(CH3) 
 2882  2884 2885 2897 2884 2894 νasym(CH2) 
  2902 2902 2908    ν(CH) 
 2932 2930 2934 2935 2932 2932 2932 ν(CH3) + δ 
(CH2) 
 2976  2978   2977  ν(CH3) + 
cholesterol 
3002        ν(CH) 
  3012 3010   3009  νasym(=CH) 
3056        ν(C6-H) + ν(C5-
H) anti-phase 
















 Four transdermal drug delivery systems (DDS) of resveratrol (RSV) were assayed and 
characterized: Liposomes (L), deformable (LD), ultradeformable (LU) and ethosomes (Etho)  
 The best DDS for RSV were deformable L (LD-RSV) with 91.8% encapsulation efficiency  
 Tween 80 and the adequate amount of ethanol contribute to the improved encapsulation  
 Ordered rearrangements between the lipids chains of LD were found after RSV adding 
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